Biomarin Pharmaceutical (BMRN) EBITDA Margin Growth (5y) (2014 - 2026)
Biomarin Pharmaceutical (BMRN) EBITDA Margin Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,176.00 |
| Dec 31, 2025 | 629.00 |
| Sep 30, 2025 | 572.00 |
| Jun 30, 2025 | 4,308.00 |
| Mar 31, 2025 | 914.00 |
| Dec 31, 2024 | 2,361.00 |
| Sep 30, 2024 | 1,440.00 |
| Jun 30, 2024 | 2,758.00 |
| Mar 31, 2024 | 2,710.00 |
| Dec 31, 2023 | 1,502.00 |
| Sep 30, 2023 | 927.00 |
| Jun 30, 2023 | 1,779.00 |
| Mar 31, 2023 | 2,234.00 |
| Dec 31, 2022 | -1,864.00 |
| Sep 30, 2022 | 363.00 |
| Jun 30, 2022 | 1,956.00 |
| Mar 31, 2022 | 132,599.00 |
| Dec 31, 2021 | 1,522.00 |
| Sep 30, 2021 | 857.00 |
| Jun 30, 2021 | 3.68 Mn |